N-(3-(4-methoxybenzylcarbamoyl)-4,5,6,7-tetrahydrobenzo[b]thiophen-2-yl)nicotinamide

ID: ALA5286422

Max Phase: Preclinical

Molecular Formula: C23H23N3O3S

Molecular Weight: 421.52

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  COc1ccc(CNC(=O)c2c(NC(=O)c3cccnc3)sc3c2CCCC3)cc1

Standard InChI:  InChI=1S/C23H23N3O3S/c1-29-17-10-8-15(9-11-17)13-25-22(28)20-18-6-2-3-7-19(18)30-23(20)26-21(27)16-5-4-12-24-14-16/h4-5,8-12,14H,2-3,6-7,13H2,1H3,(H,25,28)(H,26,27)

Standard InChI Key:  SYEFOGSFLWGBHY-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 30 33  0  0  0  0  0  0  0  0999 V2000
    1.5622   -0.5897    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2768   -0.1774    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9887   -0.5893    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9887   -1.4144    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.2786   -1.8262    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5622   -1.4181    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8476   -1.8308    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8476   -2.6559    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.1329   -1.4181    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5816   -1.8308    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5816   -2.6559    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3858   -2.9061    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8565   -2.2524    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3645   -1.5848    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5781   -0.7877    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3752   -0.5742    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9945   -0.2043    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2081    0.5927    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6246    1.1762    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8380    1.9734    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2557    2.5546    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5415    2.3409    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7554    1.5482    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1758    0.9617    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1249    2.9244    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.9113    3.7215    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7164   -3.6406    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5179   -3.7215    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9887   -3.0678    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6581   -2.3333    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  2  0
  3  2  1  0
  4  3  2  0
  5  4  1  0
  1  6  1  0
  6  5  2  0
  6  7  1  0
  7  8  2  0
  7  9  1  0
  9 10  1  0
 11 10  1  0
 11 12  1  0
 12 13  2  0
 14 13  1  0
 10 14  2  0
 14 15  1  0
 15 16  2  0
 15 17  1  0
 17 18  1  0
 18 19  1  0
 20 19  2  0
 21 20  1  0
 22 21  2  0
 23 22  1  0
 24 23  2  0
 19 24  1  0
 22 25  1  0
 25 26  1  0
 12 27  1  0
 28 27  1  0
 29 28  1  0
 30 29  1  0
 13 30  1  0
M  END

Alternative Forms

  1. Parent:

    ALA5286422

    ---

Associated Targets(Human)

MGAM Tclin Maltase-glucoamylase (654 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HepG2 (196354 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
L02 (4864 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 421.52Molecular Weight (Monoisotopic): 421.1460AlogP: 4.21#Rotatable Bonds: 6
Polar Surface Area: 80.32Molecular Species: NEUTRALHBA: 5HBD: 2
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 3.50CX LogP: 4.67CX LogD: 4.67
Aromatic Rings: 3Heavy Atoms: 30QED Weighted: 0.62Np Likeness Score: -1.87

References

1. Wang KM, Ge YX, Zhang J, Chen YT, Zhang NY, Gu JS, Fang L, Zhang XL, Zhang J, Jiang CS..  (2023)  New cycloalkyl[b]thiophenylnicotinamide-based α-glucosidase inhibitors as promising anti-diabetic agents: Synthesis, in silico study, in vitro and in vivo evaluations.,  79  [PMID:36395995] [10.1016/j.bmcl.2022.129069]

Source